Clinical Trial Update: Safety Study of PRLX 93936 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating PRLX 93936 in patients with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PRLX 93936

Snippet

Sponsor: Prolexys Pharmaceuticals | Conditions: Cancer | Phase 1 | Status: COMPLETED